Understanding the cellular responses to nano zinc oxide particles (Nano-ZnO) (<100 nm) is key to its successful novel exploitation in nanomedicine and bio-nanotechnology. Unlike other conventional inorganic compounds, zinc is an essential co-factor for numerous enzymes that are known to regulate a wide spectrum of fundamental cellular activities such as redox homeostasis, metabolism and signal transductions. In human, as many as 3000 proteins have been revealed to contain Zn 2+. In this regard, Nano-ZnO can be considered as a unique class of biologically active nanomaterials that can either disrupt (at toxic concentration) or support (at non-toxic concentration) cellular functions. While studies have shown that high concentrations of Nano-ZnO can trigger oxidative stress-mediated cell death via the generation of reactive oxygen species (ROS), little is known about the effects of Nano-ZnO and its role in mediating ROS signalling in the low-dose range. Inspired by recent demonstrations of biological systems capable of reciprocating to low level of oxidative stress via the process of cell adaptation, this project seeks to examine whether (i) cells can adapt to low dose of Nano-ZnO, (ii) understand the underlying mechanism underpinning the adaption process and (iii) conduct proof-of-concept studies to unveil the biological consequences of Nano-ZnO mediated adaption. Herein, using a "conditioning and challenge" (2Cs) experimental regime, it is showed that long term (48h-144h) exposure of sub-lethal dose of Nano-ZnO (~ 100nm) (0.5 µg/ml) to human keratinocytes (HaCaTs), could induce adaptive response and dramatically improve the overall fitness of HaCaTs to cope with toxic level of oxidative stress. As Nano-ZnO is limiting in the low dose range, it was observed a generation of discrete ROS "hotspots" (~2%) in the HaCaTs cells, which could correspond to Nano-ZnO Loaded Keratinocytes (Nano-ZLKs). Interestingly, the occurrence of these ROS "hotspots" is sufficient to trigger a population wide activation of the nuclear factor (erythroid-derived 2)-like 2 (Nrf-2) stress response pathway via a complex cross-talk between the Nano-ZLK and the "bystander" cells through paracrine signalling. Transcriptome analysis revealed that the cross-talk between these two sub-population of cells were mediated primarily via
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.